Benefits and Risks of Bariatric Surgery in Adults: A Review.
JAMA – J Am Med Assoc. 2020; 324: 879-887https://doi.org/10.1001/jama.2020.12567
Laparoscopic Sleeve Gastrectomy Then and Now: An Updated Systematic Review of the Progress and Short-term Outcomes over the Last 5 Years.
Surg Laparosc Endosc Percutaneous Tech. 2017; 27: 307-317https://doi.org/10.1097/SLE.0000000000000418
Comparison of safety and effectiveness between laparoscopic mini-gastric bypass and laparoscopic sleeve gastrectomy: A meta-analysis and systematic review.
Med (United States). 2017; 96https://doi.org/10.1097/MD.0000000000008924
A meta-analysis of 2-year effect after surgery: Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity and diabetes mellitus.
Obes Surg. 2014; 24: 1528-1535https://doi.org/10.1007/s11695-014-1303-1
Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-y gastric bypass onweight loss at 5 years among patients with morbid obesity the SLEEVEPASS randomized clinical trial.
JAMA – J Am Med Assoc. 2018; 319: 241-254https://doi.org/10.1001/jama.2017.20313
Five-year weight loss outcomes in laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: A systematic review and meta-analysis of randomized controlled trials.
Surg Laparosc Endosc Percutaneous Tech. 2020; 30: 542-553https://doi.org/10.1097/SLE.0000000000000834
A meta-analysis of the medium- And long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass.
BMC Surg. 2020; 20: 1-10https://doi.org/10.1186/s12893-020-00695-x
Revisional Bariatric Surgery Following Failed Primary Laparoscopic Sleeve Gastrectomy: A Systematic Review.
Obes Surg. 2014; 24: 1757-1763https://doi.org/10.1007/s11695-014-1332-9
Laparoscopic repeat sleeve gastrectomy versus duodenal switch after isolated sleeve gastrectomy for obesity.
Surg Obes Relat Dis. 2011; 7: 38-43https://doi.org/10.1016/j.soard.2010.08.005
Secondary surgery after sleeve gastrectomy: Roux-en-Y gastric bypass or biliopancreatic diversion with duodenal switch.
Surg Obes Relat Dis. 2015; 11: 771-777https://doi.org/10.1016/j.soard.2014.09.029
Second-stage duodenal switch for sleeve gastrectomy failure: A matched controlled trial.
Surg Obes Relat Dis. 2018; 14: 1570-1579https://doi.org/10.1016/j.soard.2018.05.008
Resleeve for failed laparoscopic sleeve gastrectomy: systematic review and meta-analysis.
Surg Obes Relat Dis. 2020; 16: 1383-1391https://doi.org/10.1016/j.soard.2020.06.007
Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass.
Obes Surg. 2018; 28: 3843-3850https://doi.org/10.1007/s11695-018-3435-1
Conversion to Gastric Bypass After Either Failed Gastric Band or Failed Sleeve Gastrectomy.
Obes Surg. 2017; 27: 83-89https://doi.org/10.1007/s11695-016-2249-2
The Exact Value of the Moments of the Distribution of χ 2 , Used as a Test of Goodness of Fit, When Expectations are Small.
Biometrika. 1939; 31: 220https://doi.org/10.2307/2334987
On Estimating Binomial Response Relations.
Biometrika. 1956; 4: 461-464https://doi.org/10.1093/biomet/43.3-4.461
Sheskin DJ. Handbook Of Parametric and Nonparametric Statistical Procedures. Vol 46. 3rd ed. Boca Raton: Chapman & Hall / CRC; 2004.
Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-yy levels after roux-en-y gastric bypass and sleeve gastrectomy a prospective, double blind study.
Ann Surg. 2008; 247: 401-407https://doi.org/10.1097/SLA.0b013e318156f012
A Randomized Clinical Trial of Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for the Treatment of Morbid Obesity in China: a 5-Year Outcome.
Obes Surg. 2014; 24: 1617-1624https://doi.org/10.1007/s11695-014-1258-2
Roux-en-Y gastric bypass, sleeve gastrectomy, or one-anastomosis gastric bypass? A systematic review and meta-analysis of randomized-controlled trials.
Obesity. 2022; 30: 614-627https://doi.org/10.1002/oby.23338
Cost-Effectiveness of Bariatric Surgery for Type 2 Diabetes Mellitus.
Med (United States). 2016; 95: 1-9https://doi.org/10.1097/MD.0000000000003522
Indications and Outcomes of Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass: a Systematic Review and a Meta-analysis.
Obes Surg. 2021; 31: 3936-3946https://doi.org/10.1007/s11695-021-05463-1
Revision of primary sleeve gastrectomy to Roux-en-Y gastric bypass: indications and outcomes from a high-volume center.
Surg Obes Relat Dis. 2016; 12: 1817-1825https://doi.org/10.1016/j.soard.2016.09.038
Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass: an audit of 34 patients.
Surg Obes Relat Dis. 2016; 12: 1646-1651https://doi.org/10.1016/j.soard.2016.02.039
Gastric bypass for obesity: Mechanisms of weight loss and diabetes resolution.
J Clin Endocrinol Metab. 2004; 89: 2608-2615https://doi.org/10.1210/jc.2004-0433
Laparoscopic re-sleeve gastrectomy as a treatment of weight regain after sleeve gastrectomy.
World J Gastrointest Surg. 2014; 6: 101https://doi.org/10.4240/wjgs.v6.i6.101
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.
Nutr Clin Metab. 2002; 16: 219-220https://doi.org/10.1016/S0985-0562(02)00158-9
Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery.
Obes Res. 2003; 11: 919-924https://doi.org/10.1038/oby.2003.126
Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass.
Obes Res. 2004; 12: 346-350https://doi.org/10.1038/oby.2004.43
Effect of Sleeve Gastrectomy on Ghrelin, GLP-1, PYY, and GIP Gut Hormones: A Systematic Review and Meta-analysis.
Ann Surg. 2020; 272: 72-80https://doi.org/10.1097/SLA.0000000000003614
Yu Y, Klem M Lou, Kalarchian MA, Ji M, Burke LE. Predictors of weight regain after sleeve gastrectomy: an integrative review. Surg Obes Relat Dis. 2019;15(6):995-1005. doi:10.1016/j.soard.2019.02.009
Do Psychosocial Variables Predict Weight Loss or Mental Health after Obesity Surgery?.
A Systematic Review. 2004; 12: 1554-1569https://doi.org/10.1038/oby.2004.195
Outcomes of Roux-en-Y gastric bypass in the super obese: Comparison of body mass index 50-60 kg/m2 and≥60 kg/m2 with the morbidly obese.
Surg Obes Relat Dis. 2016; 12: 292-296https://doi.org/10.1016/j.soard.2015.10.072
Laparoscopic gastric bypass: Risks vs. benefits up to two years following surgery in super-super obese patients.
Surgery. 2006; 140: 524-531https://doi.org/10.1016/j.surg.2006.07.002
Five-year outcomes of gastric bypass for super-super-obesity (BMI≥60 kg/m): A case matched study.
Surg Obes Relat Dis. 2015; 11: 32-37https://doi.org/10.1016/j.soard.2014.04.031
Aly A, Mori K. Laparoscopic Roux en Y gastric bypass in the super obese. Ann Transl Med. 2020;8(S1):S6-S6. doi:10.21037/atm.2020.02.167
Long-term treatment with proton pump inhibitor is associated with undesired weight gain.
World J Gastroenterol. 2009; 15: 4794-4798https://doi.org/10.3748/wjg.15.4794
Association of Proton Pump Inhibitor (PPI) use with energy intake, physical activity, and weight gain.
Nutrients. 2015; 7: 8592-8601https://doi.org/10.3390/nu7105416
Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass is Effective for Gastro-Oesophageal Reflux Disease but not for Further Weight Loss.
Obes Surg. 2017; 27: 1651-1658https://doi.org/10.1007/s11695-017-2542-8